Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 15, 2007, Pages 4323-4327

  Xiao, Yufang ^a   Araldi, Gian Luca ^a   Zhao, Zhong ^a   Brugger, Nadia ^a   Karra, Srinivasa ^a   Fischer, David ^a   Palmer, Elizabeth ^a  

^a EMD SERONO INC   (United States)

Author keywords

Prostaglandin

Indexed keywords

PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN E2 RECEPTOR AGONIST; PROSTAGLANDIN E4; PROSTAGLANDIN E4 RECEPTOR AGONIST; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; WITTIG REACTION;

ANIMALS; CELL LINE; DINOPROSTONE; HALF-LIFE; HUMANS; RATS; RECEPTORS, PROSTAGLANDIN E;

EID: 34347403843     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.05.025     Document Type: Article

References (27)

1. Funk C.D. Science 294 (2001) 1871
2. Narumiya S., Sugimoto Y., and Ushikubi F. Pharmacol. Rev. 79 (1999) 1193
3. Regan J. Life Sci. 74 (2003) 143
4. Kobayashi T., and Narumiya S. Prostaglandins Other Lipid Mediat. 68-69 (2002) 557
5. Sugimoto Y., Narumiya S., and Ichikawa A. Prog. Lipid Res. 39 (2000) 289
6. Boie Y., Stocco R., Sawyer N., Slipetz D., Ungrin M., Neuschafer-Rube F., Puschel G., Metters K., and Abranovitz M. Eur. J. Pharmacol. 340 (1997) 227
7. Breyer R.M., Bagdassarian C.K., Myers S.A., and Breyer M.D. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 661
8. Yamamoto S. Compr. Nat. Prod. Chem. 1 (1999) 255
9. Goto M.P., and Goldman A.S. Handb. Exp. Pharmacol. 124 (1997) 433 (Drug Toxicity in Embryonic Development I)
10. Collins P.W., and Djuric S.W. Chem. Rev. 93 (1993) 1533
11. Cameron, K. O.; Lefker, B. A.; Crawford, D. T.; DaSilva-Jardine, P.; DeNinno, S. L.; Gilbert, S.; Grasser, W. A.; Ke, H. Z.; Lu, B.; Owen, T. A.; Paralkar, V. M.; Thompson, D. D.; Tjoa, C. M.; Zamistoski, M. P.; Abstracts of Papers, 224th National Meeting of the American Chemical Society, Boston, MA, 2002.
12. Billot X., Chateauneuf A., Chauret N., Denis D., Greig G., Mathieu M.-C., Metters K.M., Slipetz D.M., and Young R.N. Bioorg. Med. Chem. Lett. 13 (2003) 1129
13. Zhao, Z.; Bao, B.; Brugger, N.; Fischer, D.; Giachetti, C.; Golzio, L.; Karra, S.; Marinelli, P.; McKenna, S.; Palmer, E.; Reddy, A.; Xiao, Y.; Araldi, G. Abstracts of Papers, 228th National Meeting of the American Chemical Society, Boston, MA, 2004.
14. Elworthy T.R., Brill E.R., Chiou S.-S., Chu F., Harris J.R., Hendricks R.T., Huang J., Kim W., Lach L.K., Mirzadegan T., Yee C., and Walker K.A.M. J. Med. Chem. 47 (2004) 6124
15. Brugger, N.; Bao, B.; Fischer, D.; Karra, S.; Mckenna, S.; Palmer, E.; Xiao, Y.; Zhao, Z.; Araldi, G. L. Abstracts of Papers, 230th National Meeting of the American Chemical Society, Washington, DC, 2005.
16. Zhao, Z.; Araldi, G. L.; Reddy, P. A.; Xiao, Y.; Liao, Y.; Karra, S.; Brugger, N.; Fischer, D.; Palmer, E. Bioorg. Med. Chem. Lett. submitted for publication.
17. Sum F.-W., and Weiler L. Can. J. Chem. 57 (1979) 1431
18. Yoda H., Oguchi T., and Takabe K. Tetrahedron: Asymmetry 7 (1996) 2113
19. Compounds 9a and 9b were stable up to 1 week at acidic (pH 1), neutral (pH 7.4), and basic (pH 12) conditions. No isomerization or decomposition was observed during synthesis and other handling for binding and functional assays.
20. Negishi E., Van H., David E., King A., and Okukado N. Synthesis (1979) 501
21. Bellina F., Carpita A., Fontana E., and Rossi R. Tetrahedron 50 (1994) 5189
22. Uenishi J., Kawahama R., Shiga Y., Yonemitsu O., and Tsuji J. Tetrahedron Lett. 37 (1996) 6759
23. Uenishi J., Kawahama R., Yonemitsu O., and Tsuji J. J. Org. Chem. 61 (1996) 5716
24. Uenishi J., Kawahama R., Yonemitsu O., and Tsuji J. J. Org. Chem. 63 (1998) 8965
25. Milstein D., and Stlle J.K. J. Am. Chem. Soc. 101 (1979) 4992
26. Uenishi J., Matsui K., and Wada A. Tetrahedron Lett. 44 (2003) 3093
27. Miyaura N., and Suzuki A. Chem. Rev. 95 (1995) 2457